Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
DOI: 10.1038/s41467-017-01114-1 Formulation strategies for therapeutic peptide stability pH, ionic strength, co-solvency
Its FDA approval provides a level of clinical validation that few research peptides possess
Liver-tumor hybrid organoids for modeling tumor growth and drug response in vitro
Rated 5 out of 5 Excellent Michael Adams Rated 5 out of 5 Related products UPB Cagrilintide 10MG UPB CagriSema 5MG/5MG 5.00 out of 5 UPB CJC-1295 with DAC (5MG) UPB CJC/IPA 5MG/5MG without DAC 5.00 out of 5 UPB Ipamorelin 10MG 4.50 out of 5 UPB Klow Blend ( BPC-157 10mg, TB-500 10mg, KPV 10mg and GHK-Cu 50mg) 5.00 out of 5
ROS can induce the stabilization of HIF-1, which in turn upregulates VEGF expression, promoting the formation of new blood vessels to supply the growing tumor with nutrients and oxygen [115]
US$ 26.11
US$ 28.41
US$ 23.09
US$ 23.65
US$ 28.11
US$ 23.99
US$ 26.43
US$ 27.83
US$ 25.87
US$ 24.73
